Heron Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
2.05
-0.06
(-2.84%)
Volume:
2,697,091
52 week range:
1.04 - 3.93
Market Cap:
312.755M
Company Description:
Heron Therapeutics, Inc. engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy.